» Articles » PMID: 9797384

Antibiotic Resistance in Helicobacter Pylori: Implications for Therapy

Overview
Specialty Gastroenterology
Date 1998 Oct 31
PMID 9797384
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Helicobacter pylori is a conventional gram-negative bacteria that causes an infection of the gastric mucosa. The organism is sensitive to most common antibiotics and theoretically should be easy to eradicate, provided that the patient takes antibiotics to which the organism is sensitive using a sufficient dose and duration of therapy. Unfortunately, the infection has proved difficult to cure. There are many other examples of bacterial infections that resist treatment with antibiotics even when the individual organisms demonstrate antibiotic sensitivity in vitro (e.g., Salmonella in the biliary tract). Failure can be due to the presence of antibiotic-resistant organisms, features of the infection may make it inaccessible to the antibiotics despite having antibiotic-sensitive organisms (a resistant infection), or both. Acquired resistance of H. pylori to clarithromycin, metronidazole, tetracycline, and amoxicillin have all been described.

Citing Articles

Best Practices for Management.

Graham D Gastroenterol Hepatol (N Y). 2024; 20(3):159-168.

PMID: 38680170 PMC: 11047161.


Antibiotic Resistance of : Mechanisms and Clinical Implications.

Hasanuzzaman M, Bang C, Gong E J Korean Med Sci. 2024; 39(4):e44.

PMID: 38288543 PMC: 10825452. DOI: 10.3346/jkms.2024.39.e44.


Rifabutin as salvage therapy for eradication: Cornerstones and novelties.

Borraccino A, Celiberto F, Pricci M, Girardi B, Iannone A, Rendina M World J Gastroenterol. 2022; 28(45):6356-6362.

PMID: 36533106 PMC: 9753051. DOI: 10.3748/wjg.v28.i45.6356.


Curcumin Oxidation Is Required for Inhibition of Growth, Translocation and Phosphorylation of Cag A.

Ray A, Luis P, Mishra S, Barry D, Asim M, Pandey A Front Cell Infect Microbiol. 2022; 11:765842.

PMID: 35004346 PMC: 8740292. DOI: 10.3389/fcimb.2021.765842.


diagnosis and therapy in the era of antimicrobial stewardship.

Shiotani A, Roy P, Lu H, Graham D Therap Adv Gastroenterol. 2022; 14:17562848211064080.

PMID: 34987609 PMC: 8721397. DOI: 10.1177/17562848211064080.